(Q43696432)

English

Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL.

scientific article published in February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Christina Voelkel-Johnson

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Deanne Lea King

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

James Scott Norris

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

164-172

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700420

0 references

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

21 January 2018

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

21 January 2018

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

21 January 2018

Sensitization of human colon cancer cells to TRAIL-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

21 January 2018

Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

21 January 2018

The potential of TRAIL for cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

21 January 2018

Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

21 January 2018

The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

21 January 2018

Adenoviral vector which delivers FasL-GFP fusion protein regulated by the tet-inducible expression system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

21 January 2018

Creation of a new transgene cloning site near the right ITR of Ad5 results in reduced enhancer interference with tissue-specific and regulatable promoters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

21 January 2018

Green fluorescent protein as a novel tool to measure apoptosis and necrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

21 January 2018

Apoptosis signaling by death receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

21 January 2018

Tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

21 January 2018

Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

21 January 2018

KILLER/DR5, a novel DNA-damage inducible death receptor gene, links the p53-tumor suppressor to caspase activation and apoptotic death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

21 January 2018

Widely used prostate carcinoma cell lines share common origins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

21 January 2018

Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

21 January 2018

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

7 January 2021

based on heuristic

inferred from DOI database lookup

Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700420

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700420

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43696432&oldid=2102646366"